Cargando…
Real-Time Monitoring of Tumorigenesis, Dissemination, & Drug Response in a Preclinical Model of Lymphangioleiomyomatosis/Tuberous Sclerosis Complex
BACKGROUND: TSC2-deficient cells can proliferate in the lungs, kidneys, and other organs causing devastating progressive multisystem disorders such as lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC). Preclinical models utilizing LAM patient-derived cells have been difficult to es...
Autores principales: | Liu, Fangbing, Lunsford, Elaine P., Tong, Jingli, Ashitate, Yoshitomo, Gibbs, Summer L., Yu, Jane, Choi, Hak Soo, Henske, Elizabeth P., Frangioni, John V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376142/ https://www.ncbi.nlm.nih.gov/pubmed/22719903 http://dx.doi.org/10.1371/journal.pone.0038589 |
Ejemplares similares
-
MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM)
por: Trindade, Anil J., et al.
Publicado: (2013) -
Lymphangioleiomyomatosis Associated with Tuberous Sclerosis Complex
por: Tanitame, Keizo
Publicado: (2020) -
Tuberous sclerosis complex associated lymphangioleiomyomatosis
por: Han, Z, et al.
Publicado: (2023) -
Serum endostatin levels are associated with diffusion capacity and with tuberous sclerosis- associated lymphangioleiomyomatosis
por: Lamattina, Anthony M., et al.
Publicado: (2019) -
Pneumothorax as a Presentation of Tuberous Sclerosis-Associated Lymphangioleiomyomatosis
por: Silva, Duarte Lages, et al.
Publicado: (2019)